Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Items 401–500 of 630
Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation
King, O. G., Yip, A., Horrocks, V., Blanco, J. M., Marchesi, J. R., Mullish, B. H., Clarke, T. B., & McDonald, J. A. K. (2025) · Nature Communications · doi:10.1038/s41467-025-61731-z · Cited by 24
Tyszka, M., Biliński, J., & Basak, G. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112508 · Cited by 22
“Increased intestinal REG3 was observed after IL-22 [48], lipopolysaccharide [53] or propionate [50] administration.”
BackgroundYoshioka, N., Taniguchi, Y., Yoshida, A., Nakata, K., Nishizawa, T., Inagawa, H., Kohchi, C., & Soma, G. (2009) · PubMed · Cited by 20
Xie, P., Ma, Z., Yang, X., Pan, H., Shen, P., Du, H., Cao, Y., Xiao, J., Xiao, H., & Song, M. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2481983 · Cited by 23
“Additionally, it induces the expression of AMPs, such as Reg3c, or activates innate immunity in the mucosa through the TLR-MyD88 pathway (Brandl et al. 2008).”
Wang, S., Li, X., Zhang, M., & Li, M. (2025) · Microbiome · doi:10.1186/s40168-025-02152-4 · Cited by 26
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.
Righi, E., Lambertenghi, L., Górska, A., Sciammarella, C., Ivaldi, F., Mirandola, M., Sartor, A., & Tacconelli, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112786 · Cited by 21
“Vancomycin has been associated with reduced proportion of Tregs and Th17, neutrophil-mediated killing, altered expression of bactericidal compounds and with selection of Gram-positive organisms such as vancomycin-resistant enterococci [34,35].”
BackgroundGaca, A. O., & Gilmore, M. S. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1127482 · Cited by 22
Santiago, M., 1 Finch Therapeutics, 2. I. B. R., Eysenbach, L. M., Allegretti, J. R., Aroniadis, O. C., Brandt, L. J., Fischer, M., Grinspan, A. M., Kelly, C. R., Morrow, C. D., et al. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.1.1 · Cited by 20
“microbiome is required for the stimulation of the antimicrobial lectin, Reg3, which targets Gram positive pathogens in the intestine, including VRE [7].”
BackgroundShi, Y., Luo, J., Narbad, A., & Chen, Q. (2023) · Microorganisms · doi:10.3390/microorganisms11010179 · Cited by 26
“The antibiotic treatment was reported to influence the expression of Reg3γ, and the oral supplementation of LPS can reverse this deficiency [57].”
BackgroundLiu, Y., Luan, C., Xia, X., An, S., & Wang, Y. (2011) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-011-9255-y · Cited by 19
“The use of broad-spectrum antibiotics is ubiquitous in the pig industry, inducing drug-resistant bacteria and, disturbing the balance of microbiota in the intestine (Brandl et al. 2008).”
BackgroundNakai, K., Kubota, Y., Soma, G., & Kohchi, C. (2018) · In Vivo · doi:10.21873/invivo.11446 · Cited by 19
Chiang, D., Dingle, T. C., Belga, S., Kabbani, D., Bhanji, R. A., Walter, J., Abraldeṣ, J. G., & Cervera, C. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13821 · Cited by 18
“CMV infection§ • CMV infection 15 (16) 44 (18) .”
Geraldes, C., Verdial, C., Cunha, E. S., Almeida, V., Tavares, L. M., Oliveira, M., & Gil, S. (2021) · Antibiotics · doi:10.3390/antibiotics10060639 · Cited by 21
Wittmann, A., Autenrieth, I. B., & Frick, J.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071338 · Cited by 18
Mu, J., Chen, Q., Zhu, L., Wu, Y., Liu, S., Zhao, Y., & Ma, T. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1470085 · Cited by 18
Fitness Landscape of the Immune Compromised Favors the Emergence of Antibiotic Resistance
Margolis, E. B., & Rosch, J. W. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00158 · Cited by 17
Conserved genetic basis for microbial colonization of the gut
Liu, M., Blattman, S. B., Takahashi, M., Nandan, M. O., Jiang, W., Oikonomou, P., Tavazoie, S. F., & Tavazoie, S. (2025) · Cell · doi:10.1016/j.cell.2025.03.010 · Cited by 19
Overview of the Effect of Citrobacter rodentium Infection on Host Metabolism and the Microbiota
Hopkins, E. G. D., & Frankel, G. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1339-9_20 · Cited by 19
Gut microbiota involved in myocardial dysfunction induced by sepsis
Xiao, K., Sun, Y., Song, J., Li, L., Mao, W., & Jiang, C. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.105984 · Cited by 16
Migliore, G. S., Campana, S., Barberi, C., Pasquale, C. D., Pezzino, G., Cavaliere, R., Orecchia, P., Ginestra, G., Mandalari, G., Zotto, G. D., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad003 · Cited by 18
Zhao, C., Guo, G., Li, Z., Chen, J., & Ren, Y. (2023) · Aquaculture International · doi:10.1007/s10499-023-01225-1 · Cited by 16
IL-22-dependent responses and their role during Citrobacter rodentium infection
Melchior, K., Gerner, R. R., Hossain, S., Nuccio, S., Moreira, C. G., & Raffatellu, M. (2024) · Infection and Immunity · doi:10.1128/iai.00099-24 · Cited by 18
“Members of the Reg3 protein family exert direct antibacterial activity by binding to components of bacterial membranes, including peptidoglycan (10, 61) and lipid A (41), which assists the host in controlling infections (62, 63).”
BackgroundFurlan, S., Matos, R. C., Kennedy, S., Doublet, B., Serror, P., & Rigottier‐Gois, L. (2019) · mSphere · doi:10.1128/msphere.00310-19 · Cited by 17
Kırkızlar, T. A., Akalın, H., Kırkızlar, H. O., Özkalemkaş, F., Özkocaman, V., Kazak, E., Özakın, C., Bulbul, E. N., Ozboz, E. S., & Ali, R. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106463 · Cited by 17
Influence of natural gut flora on immune response
Strzępa, A., & Szczepanik, M. (2013) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1064563 · Cited by 20
“W konsekwencji określony profil flory jelitowej, poprzez indukcję AMP, wpływa na eliminację bakterii wrażliwych na AMP wywołując zjawisko, które można określić jako „samosegregację bakterii” [102].”
InfluentialControl of mucosal polymicrobial populations by innate immunity
Summers, K. L., & Huffnagle, G. B. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01347.x · Cited by 18
“Brandl et al. (2008) found that eliminating commensal bacteria with antibiotics, led to an outgrowth of enterococci.”
BackgroundTurner, M. P., Hulzen, L. V., Guse, K., Agany, D. D. M., & Pietri, J. E. (2024) · iScience · doi:10.1016/j.isci.2024.111293 · Cited by 16
Yu, J., Xiao, B., Qiu, J., Tang, Y., Guo, Y., Yang, L., Li, N., & Jiang, K. (2025) · Nano Energy · doi:10.1016/j.nanoen.2025.110691 · Cited by 15
Koh, A. Y. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006342 · Cited by 17
Reciprocal Regulation of PASTA Kinase Signaling by Differential Modification
Labbe, B. D., Hall, C. L., Kellogg, S. L., Chen, Y., Koehn, O. J., Pickrum, A. M., Mirza, S. P., & Kristich, C. J. (2019) · Journal of Bacteriology · doi:10.1128/jb.00016-19 · Cited by 16
Role of Microbial Flora and Probiotics in Host Immune Homeostasis
Mishra, P., & Mishra, S. K. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.81018 · Cited by 18
“The antibiotic-resistant strains of microbes also serve as a lasting reservoir for resistance genes in the gut microenviron ment (De La Cochetière et al., 2008; Brandl et al., 2008).”
BackgroundCho, K., Spasova, D. S., Hong, S., Eunju, O., Surh, C. D., Im, S., & Kim, K. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666088 · Cited by 16
“IECsresponded toLPS throughTLR4signalingand inducedReg3g expression (31).”
Enterococcal Peritonitis in Peritoneal Dialysis Patients: Last Name Matters
Fontán, M. P., Rodríguez–Carmona, A., & Rodríguez–Mayo, M. (2011) · Peritoneal Dialysis International · doi:10.3747/pdi.2011.00022 · Cited by 15
“These phenomena are a consequence of the eradication of gram-negative bacteria (mainly anaerobes), which results in downregulation of the intestinal expression of the antimicrobial peptide Reg IIIγ, the latter being essential to control the proliferation of gram-positive intestinal micro-organisms (3).”
BackgroundAntibiotic therapy and necrotizing enterocolitis
Pace, E. K., Yanowitz, T. D., Waltz, P. K., & Morowitz, M. J. (2023) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2023.151308 · Cited by 18
Janice, J., Wagner, T. M., Olsen, K. S., Hegstad, J., & Hegstad, K. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.12.010 · Cited by 14
Farmer, N., Morton, V. H., & Morris, R. K. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.11.026 · Cited by 16
Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
Scheithauer, T. P. M., Bakker, G. J., Winkelmeijer, M., Davids, M., Nieuwdorp, M., van Raalte, D. H., & Herrema, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1875109 · Cited by 15
The regenerating protein 3A: a crucial molecular with dual roles in cancer
Wang, L., Quan, Y., Zhu, Y., Xie, X., Wang, Z., Wang, L., Wei, X., & Che, F. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06904-x · Cited by 16
Inagawa, H., Kohchi, C., & Soma, G. (2014) · PubMed · Cited by 14
Skaradzińska, A., Łusiak-Szelachowska, M., Skaradziński, G., Jończyk‐Matysiak, E., Weber‐Dąbrowska, B., Żaczek, M., Maj, T., Sławek, A., Rymowicz, W., Kłak, M., et al. (2013) · Viral Immunology · doi:10.1089/vim.2012.0071 · Cited by 13
Umenai, T., Hirai, H., Shime, N., Nakaya, T., Asahara, T., Nomoto, K., Kita, M., Tanaka, Y., & Imanishi, J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0905-3 · Cited by 13
“broad-spectrum antibiotics downregulate the intestinal expression of TLR-associated molecules (RegIIIγ) and markedly decrease the killing of vancomycin-resistant enterococci in vivo [ 43 ].”
BackgroundBelga, S., Chiang, D., Kabbani, D., Abraldeṣ, J. G., & Cervera, C. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1607297 · Cited by 16
“Activation of TLR 4 and TLR 5 will then upregulate production of RegIIIΥ [67,77,78].”
BackgroundMears, K. S., Denny, J. E., Maslanka, J. R., Mdluli, N. V., Hulit, E. N., Matsuda, R., Furth, E. E., Buffie, C. G., & Abt, M. C. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115438 · Cited by 13
Frisina, P. G., Kutlik, A. M., & Barrett, A. M. (2012) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2012.10.012 · Cited by 12
Kathleen, G. L., Lertpiriyapong, K., Piersigilli, A., Dobtsis, I., Wipf, J. R. K., Littmann, E. R., Leiner, I. M., Pamer, E. G., Arbona, R. J. R., & Lipman, N. S. (2020) · Comparative Medicine · doi:10.30802/aalas-cm-19-000109 · Cited by 14
Self-citationZhang, C. J., Yu, M., Yang, Y., Mu, C., Su, Y., & Zhu, W. (2020) · animal · doi:10.1017/s1751731120001044 · Cited by 14
Mu, A., Carter, G. P., Li, L. Q., Isles, N. S., Vrbanac, A. F., Morton, J. T., Jarmusch, A. K., Souza, D. P. D., Narayana, V. K., Kanojia, K., et al. (2020) · mSystems · doi:10.1128/msystems.00452-20 · Cited by 12
“cules produced by bacteria in the intestinal mucosa (9).”
BackgroundIntestinal microbiota: The hidden gems in the gut?
Piewngam, P., Mets, F. D., & Otto, M. J. (2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-020720-0897 · Cited by 20
Mascari, C. A., Little, J. L., & Kristich, C. J. (2023) · Molecular Microbiology · doi:10.1111/mmi.15150 · Cited by 16
“Administration of cephalosporins can lead to abnormal proliferation of these resistant organisms and subsequent dissemination (Brandl et al., 2008; Donskey et al., 2000; Ubeda et al., 2010) resulting in urinary tract infections, bacteremia, endocarditis, and other infections (Magill et al., 2018;…”
BackgroundFinding a Sugary Foothold: How Antibiotics Pave the Way for Enteric Pathogens
Stecher, B. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.008 · Cited by 13
“Oral application of lipopolysaccharide (LPS) rescued RegIIIg expression in antibiotictreated mice, suggesting that a decrease of microbiota-derived Toll-like receptor (TLR) ligands upon antibiotic treatment is causally involved.”
BackgroundInfluentialChen, C.-P., Jing, R., & Wickstrom, E. (2017) · ACS Omega · doi:10.1021/acsomega.6b00567 · Cited by 12
Trevisi, P., Corrent, E., Messori, S., Formica, S., Priori, D., & Bosi, P. (2012) · Livestock Science · doi:10.1016/j.livsci.2012.04.008 · Cited by 13
“REG3G and SFTPD are C-type lectins with antimicrobial activity (Brandl et al., 2008) or aggregating properties (Hogenkamp et al.”
BackgroundMizobuchi, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110583 · Cited by 11
“show that OAL re-induces RegIIIg to enhance innate immunity against vancomycin-resistant bacteria (20).”
BackgroundHarvesting the biological potential of the human gut microbiome
Willing, B. P., Antunes, L. C. M., Keeney, K. M., Ferreira, R. B. R., & Finlay, B. B. (2011) · BioEssays · doi:10.1002/bies.201100030 · Cited by 11
Djorić, D., & Kristich, C. J. (2017) · Journal of Bacteriology · doi:10.1128/jb.00392-17 · Cited by 13
Konishi, H., Matsumoto, S., Namikawa, K., & Kiyama, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395301 · Cited by 12
Dead Bacteria Reverse Antibiotic-Induced Host Defense Impairment in Burns
Chen, L.-W., Chen, P.-H., Fung, C.-P., & Hsu, C.-M. (2014) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.04.016 · Cited by 11
“It has been shown that expression of RegIII γ is dependent on TLR-MyD88-mediated signaling in intestinal epithelial cells and is induced by commensal microbes (15).”
BackgroundOgita, T., Namai, F., Mikami, A., Ishiguro, T., Umezawa, K., Uyeno, Y., & Shimosato, T. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.701466 · Cited by 12
“In addition, Reg3γ can be regulated by bacterial ligands through Toll like receptor (TLR)/Myd88 signals (10).”
BackgroundEnterococcus research: recent developments and clinical challenges
Sundsfjord, A., & Willems, R. J. L. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2010.03215.x · Cited by 11
Tian, L., Chen, S., Liu, H., Guo, M., Xu, W., He, X., Luo, Y., Qi, X., Luo, H., & Huang, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164771 · Cited by 11
“The challenges of antibiotics to the gut microbiota include alteration in bacterial membership [3] and reduction of the immune responses in peripheral organs [4].”
Gut Microbiome and Host Defense Interactions during Critical Illness
Schuijt, T. J., van der Poll, T., & Wiersinga, W. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_4 · Cited by 10
“Antibiotic treatment – which is standard of care for all patients with sepsis – depletes the gut microbiome and is associated with diminished cytokine production in the gut [37, 38] (Fig.”
BackgroundStachyose inhibits vancomycin-resistant Enterococcus colonization and affects gut microbiota in mice
Zhu, S., Li, X., Song, L., Huang, Y., Xiao, Y., Chu, Q., Kang, Y., Duan, S., Wu, D., & Ren, Z. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105094 · Cited by 12
Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients
Rafey, A., Nizamuddin, S., Qureshi, W., Anjum, A., & Parveen, A. (2022) · Cureus · doi:10.7759/cureus.31335 · Cited by 10
“Our results confirmed the findings of prior studies that the use of broad-spectrum antibiotics [5-7,9-13], previous hospitalization, ischemic heart disease, renal failure, hematological malignancy, diabetes mellitus [7,9, 11,14], and previous chemotherapy [13] increased the risk of VRE.”
BackgroundResultAberrant Tissue Localization of Fungus-Specific CD4+ T Cells in IL-10-Deficient Mice
Rivera, A., Collins, N., Stephan, M. T., Lipuma, L., Leiner, I. M., & Pamer, E. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900396 · Cited by 10
“Therefore, IL-10 / and control animals were treated with an antibiotic mixture of metronidazole, neomycin, and vancomycin (MNV), previously shown to greatly diminish the intestinal microbial flora (45, 46).”
BackgroundSelf-citationNelson, M. E., Little, J. L., & Kristich, C. J. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-24 · Cited by 9
Which species are in your feces?
Zaph, C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci45263 · Cited by 10
Koh, A. Y. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.259499 · Cited by 9
The enterococcal PASTA kinase: A sentinel for cell envelope stress
Djorić, D., Minton, N. E., & Kristich, C. J. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12313 · Cited by 12
“…of the intestinal microbial ecosystem by antibiotics enables enterococci to proliferate to abnormally high numbers in the gut, then disseminate to cause infections elsewhere in the body (Brandl et al., 2008; Carmeli et al., 2002; Donskey et al., 2000; Shepard and Gilmore, 2002; Ubeda et al., 2010).”
BackgroundZhang, Y., Zhang, J., Xu, T., Zhang, C., Yu, W., Wei, T., Zhang, B., Chen, Q., Qiu, J., Li, H.-J., et al. (2021) · Journal of Immunology Research · doi:10.1155/2021/6417658 · Cited by 9
“Furthermore, it has been reported that systemic administration of flagellin or LPS induced RegIIIγ expression in intestinal epithelial and paneth cells, which could kill G bacteria [13, 20].”
Tang, Z. R., Sun, Z., Tang, X., Feng, Z., Zhou, D., Xiao, D., Zhang, B., & Li, L. L. (2011) · Journal of Applied Animal Research · doi:10.1080/09712119.2011.565570 · Cited by 9
“Use of antibiotics as growth promoters is being discouraged due to various seasons viz. drug residues in edible animal products (Cassel and Mekalanos 2001), reduction in innate immune function (Katharina et al. 2008), etc.”
BackgroundLactobacillus salivarius reverse antibiotic-induced lung defense impairment in a ventilator model
Tsay, T.-B., Yang, M.-C., Chang, W., Chen, P.-H., & Chen, L.-W. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1597-1 · Cited by 11
Soma, G., Oda, M., Tjhin, V. T., Kohchi, C., & Inagawa, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563484 · Cited by 8
Jan, A., Bayle, P., Mohellibi, N., Lemoine, C., Pepke, F., Béguet-Crespel, F., Jouanin, I., Tremblay‐Franco, M., Laroche, B., Serror, P., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02127-5 · Cited by 8
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
Strategies for biofilm inhibition: the role of synthetic drug- and nanotechnology-based agents
Rathod, N. V., & Mishra, S. K. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04556-0 · Cited by 8
“Furthermore, these aggregates have been linked to several illnesses, such as middle ear infections, chronic infections, and persistent wounds (McKenney et al. 1998; Aaron et al. 2002; Brandl et al. 2008; Liu et al. 2024 ; Moreau-Marquis et al. 2008 ).”
DCs: a dual bridge to protective immunity
Sallusto, F. (2013) · Nature Immunology · doi:10.1038/ni.2693 · Cited by 8
Six Cases of Severe Acute Pancreatitis Complicated With Vancomycin-Resistant Enterococcus Enteritis
Zhang, Y., Gao, S.-L., Zhang, S.-Y., Liang, Z.-Y., Yu, W.-Q., & Liang, T.-B. (2014) · Shock · doi:10.1097/shk.0000000000000237 · Cited by 8
“(19) found that broad-spectrum antibiotics were able to promote the development of VRE, partially through inhibition”
BackgroundLACTATEing Salmonella: A Host-Derived Fermentation Product Fuels Pathogen Growth
Stecher, B., & Jung, K. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.012 · Cited by 8
“Antibiotics open up niches for the pathogen by elimination of competing species, inhibitors (Buffie et al., 2015), liberationofmucosal carbohydrates (Ng et al., 2013), or impairment of immune responses (Brandl et al., 2008).”
Faivre, J., Shalhoub, H., Nguyen, T.-S., Xie, H., & Moniaux, N. (2025) · Cancers · doi:10.3390/cancers17142395 · Cited by 9
“A key driver of REG3A expression in the gut is bacterial colonization [19,31].”
A Hen in the Wolf Den: A Pathobiont Tale
Guerrini, M. M., Vogelzang, A., & Fagarasan, S. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.003 · Cited by 7
Enterococcal Infections and Drug Resistance Mechanisms
Sarathy, M. V., Balaji, S., & Rao, T. J. M. (2020) · Springer eBooks · doi:10.1007/978-981-15-1695-5_9 · Cited by 14
Huang, X., Gong, F., Lu, Z., Zhu, J., & Yu, Q. (2020) · European Journal of Inflammation · doi:10.1177/2058739220917490 · Cited by 10
Protocol to assess the impact of early-life antibiotic exposure on murine longevity
Lynn, M. A., Ryan, F. J., Tee, Y. C., Benson, S. C., & Lynn, D. J. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101220 · Cited by 9
“, 2018), cocktails of three (Candon et al., 2015; Kim et al., 2017; Brandl et al., 2008), four (Ganal et al.”
BackgroundMethodDewaxed Brown Rice Feed Improves Fatty Liver in Obese and Diabetic Model Mice
Inagawa, H., Saika, T., NISHIYAMA, N., NISHIZAWA, T., Kohchi, C., Uenobe, M., & Soma, G. (2018) · Anticancer Research · doi:10.21873/anticanres.12734 · Cited by 7
Francino, M. P., & Moyá, A. (2013) · EMJ Gastroenterology · doi:10.33590/emjgastroenterol/10311405 · Cited by 8
Mukherjee, S., & Ramesh, A. (2017) · Microbiology · doi:10.1099/mic.0.000561 · Cited by 9
AMPs and Mechanisms of Antimicrobial Action
Furci, L., & Secchi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814319-3.00006-4 · Cited by 7
Wu, T., Zhang, F., Liu, H., Ma, F., Yu, Y., Sun, D., Ren, J., Wang, W., Elsabahy, M., & Gao, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114400 · Cited by 8
Allied Commensal Forces against Vancomycin-Resistant Enterococci
Fremin, B. J., & Bhatt, A. S. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.015 · Cited by 6
“While early work suggests that antibiotics downregulate intestinal RegIIIα and thus potentiate colonization, a growing body of evidence suggests that a loss of commensal microbes upon antibiotic exposure also plays a direct role in modulating the colonizing ability of VRE (Brandl et al., 2008).”
BackgroundEsposito, P., Kearns, M. M., Smith, K. B., Chandrasegaram, R., Kadamani, A. K., Gandelman, M., Liang, J., Nikpoor, N., Tompkins, T. A., & Ismail, N. (2022) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2022.100147 · Cited by 7
Ramirez, Z. E., & Surana, N. K. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200096 · Cited by 8
The complexities of bacterial-fungal interactions in the mammalian gastrointestinal tract
López‐Medina, E., & Koh, A. Y. (2016) · Microbial Cell · doi:10.15698/mic2016.05.497 · Cited by 7
Improvement Effect of Dewaxed Brown Rice on Constipation in Antibiotic-treated Mice
Inagawa, H., Saika, T., NISHIYAMA, N., NISHIZAWA, T., Kohchi, C., Uenobe, M., & Soma, G. (2017) · In Vivo · doi:10.21873/invivo.11096 · Cited by 6
Vancomycin-resistant enterococcus, obesity and antibiotics: Is there a possible link?
Wada, Y., Harun, A. B., Yean, C. Y., Nasir, N. S. M., & Zaidah, A. R. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100226 · Cited by 8
Control of Health Care-associated Infections (HAI): Winning Both the Battles and the War
Ehrenkranz, N. J., MacIntyre, A. T., Hebert, P. R., Schneider, W. R., & Hennekens, C. H. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1521-8 · Cited by 6
“Loss of normal colonizing flora compromises the mucosal immune system, which offers a plausible mechanism to explain why heavily colonized persons disseminate antibiotic-resistant organisms for prolonged periods.(19) Hence, certain antibiotics administered in the community to individuals subsequently hospitalized are…”
BackgroundHendrickx, A. P. A., van de Kamer, D., & Willems, R. J. L. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.602 · Cited by 7
“Antibiotic administration deregulates gut homeostasis (Brandl et al., 2008; Vaishnava et al., 2011), leads to a reduced Muc- 2 mucus layer and affects E- cadherin junctions (Hendrickx et al.”
BackgroundHu, S., Liu, Z., Yan, W., & Guo, R. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013494 · Cited by 8
“For instance, microbial depletion by antibiotic administration reduces RegIII γ expression, impairing the clearance of vancomycin-resistant Enterococcus [116].”
Qi, X., Zhang, Y., Sun, Z., Wang, G., & Ling, F. (2025) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2025.10.011 · Cited by 6
“According to the established protocol, recipient fish were administered antibiotics to eliminate intestinal bacteria [23,24].”
Understanding the influence of the microbiome on childhood infections
Heston, S. M., Hurst, J. H., & Kelly, M. S. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2340664 · Cited by 7
Yamanaka, H., Takagi, T., Ohsawa, M., Yamamoto, N., Kubo, N., Takemoto, T., Sasano, S., Masuyama, R., & Ohsawa, K. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.63.297 · Cited by 6
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.